Evolution of Lantibiotic Salivaricins: New Weapons to Fight Infectious Diseases.

Abdelahhad Barbour, Philip Wescombe, Leif Smith

Journal: Trends in microbiology 2021;28(7):578-593

PMID: 32544444

Abstract

Lantibiotic salivaricins are polycyclic peptides containing lanthionine and/or β-methyllanthionine residues produced by certain strains of Streptococcus salivarius, which almost exclusively reside in the human oral cavity. The importance of these molecules stems from their antimicrobial activity towards relevant oral pathogens which has so far been applied through the development of salivaricin-producing probiotic strains. However, salivaricins may also prove to be of great value in the development of new and novel antibacterial therapies in this era of emerging antibiotic resistance. In this review, we describe the biosynthesis, antimicrobial activity, structure, and mode of action of the lantibiotic salivaricins characterized to date. Moreover, we also provide an expert opinion and suggestions for future development of this important field of microbiology.

Copyright © 2020 Elsevier Ltd. All rights reserved.

Address: Faculty of Dentistry, University of Toronto, Toronto, ON, Canada. Electronic address: [email protected].; Yili Innovation Center Oceania, Lincoln University, Christchurch, New Zealand.; Department of Biology, College of Science, Texas A&M University, College Station, TX, USA.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.